Joseph Kim, Inovio CEO (Andrew Harnik, AP Images)
Positive Covid-19 vaccine data? New mouse study? OWS inclusion? Yep, but somehow, the usual tidbits from Inovio backfire
You don’t go more than 40 years in biotech without ever getting a product to market unless you can learn the art of writing a …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.